[68Ga]PSMA PET/CT Improves Initial Staging and Management Plan of Patients with High-Risk Prostate Cancer.

Nader HirmasAkram N Al-IbraheemKen HerrmannAbedalatif AlsharifHaider MuhsinJamal KhaderAli Al-DaghminSamer Salah

Published in: Molecular imaging and biology (2020)

[68Ga]PSMA PET/CT is an invaluable imaging modality in the assessment of primary high-risk PCa with great potential for the detection of lymph node spread and bone metastases that would impact the management plan.

Keyphrases

pet ct
lymph node
prostate cancer
positron emission tomography
radical prostatectomy
neoadjuvant chemotherapy
computed tomography
radiation therapy
mass spectrometry
human health
fluorescence imaging
quantum dots